NCT04811079

The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: Johnson & Johnson Vision Care, Inc. · Industry
• Sex: All
• Age: 18 Years – 30 Years
• Healthy volunteers: Accepted

Summary

This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.

Conditions

• Photosensitivity

Interventions

Type	Name	Description
OTHER	419 nm Spectacle Filter	TEST
OTHER	437 nm Spectacle Filter	TEST
OTHER	456 nm Spectacle Filter	TEST
OTHER	476 nm Spectacle Filter	TEST
OTHER	373 nm Spectacle Filter	CONTROL

Timeline

• Start date: 2021-07-14
• Primary completion: 2022-05-16
• Completion: 2022-05-16
• First posted: 2021-03-23
• Last updated: 2025-04-25

Locations

1 site across 1 country: United States